CorVel Corporation (CRVL)
For informational purposes only. Not financial advice.
CorVel Corporation (CRVL) is a publicly traded company trading at $50.57 with a market cap of $2.59B. It holds a cautious AI score of 46/100 based on fundamental, technical, and sentiment analysis.
CorVel Corporation provides technology-driven risk management solutions, including claims management and healthcare cost containment. The company leverages AI and data analytics to optimize outcomes for employers, insurers, and government agencies.
Company Overview
CorVel Corporation offers a compelling investment opportunity driven by its technology-enabled risk management solutions, strong market position in workers' compensation, and potential for expansion into adjacent healthcare markets, making it a leader in cost containment and care optimization.
Investment Thesis
CorVel Corporation presents a compelling investment opportunity due to its established market position, consistent profitability, and growth potential within the risk management sector. The company's focus on technology-driven solutions, particularly the application of AI and machine learning, provides a competitive edge in optimizing healthcare cost containment and care management. With a P/E ratio of 23.68 and a healthy profit margin of 11.2%, CorVel demonstrates financial stability. Key growth catalysts include expanding its network solutions and patient management services, as well as penetrating new markets. The increasing demand for efficient healthcare cost management, coupled with CorVel's innovative technology, positions the company for sustained growth and value creation.
Key Highlights
- Market capitalization of $2.49 billion, reflecting investor confidence in CorVel's market position and growth prospects.
- P/E ratio of 23.68, indicating a reasonable valuation relative to earnings.
- Profit margin of 11.2%, demonstrating efficient operations and profitability.
- Gross margin of 24.2%, showcasing the company's ability to manage costs effectively.
- Beta of 1.06, suggesting that the stock's volatility is similar to the overall market.
Competitors
Strengths
- Strong market position in workers' compensation solutions.
- Proprietary technology platform with AI and machine learning capabilities.
- Established relationships with a diverse customer base.
- Consistent profitability and positive cash flow.
Weaknesses
- Reliance on a limited number of large clients.
- Exposure to regulatory changes in the healthcare industry.
- Competition from larger, more diversified companies.
- Potential for technological disruption from new entrants.
Catalysts
- Upcoming: Expansion of AI-powered claims management solutions to new clients by Q3 2026.
- Ongoing: Increasing adoption of value-based care models driving demand for patient management services.
- Ongoing: Strategic partnerships with healthcare providers to expand network reach.
- Ongoing: Continued investment in technology innovation to enhance service offerings.
Risks
- Potential: Economic downturn impacting healthcare spending and client budgets.
- Potential: Increased competition from larger, more diversified companies.
- Ongoing: Cybersecurity risks and potential data breaches.
- Potential: Changes in healthcare regulations and reimbursement models.
- Ongoing: Reliance on key personnel and potential loss of talent.
Growth Opportunities
- Expansion of Network Solutions: CorVel can further expand its network solutions services, including automated medical fee auditing and preferred provider management. The market for these services is estimated to be substantial, driven by the increasing complexity of healthcare billing and the need for cost containment. By leveraging its technology platform and established network, CorVel can capture a larger share of this market, leading to increased revenue and profitability. Timeline: Ongoing.
- Growth in Patient Management Services: CorVel's patient management services, such as claims management and case management, represent a significant growth opportunity. The demand for these services is increasing as employers and insurers seek to improve patient outcomes and reduce costs associated with healthcare claims. By expanding its patient management capabilities and geographic reach, CorVel can attract new clients and drive revenue growth. Timeline: Ongoing.
- Penetration of New Markets: CorVel can expand its presence in new geographic markets and industry segments. The company's risk management solutions are applicable to a wide range of industries, including healthcare, manufacturing, and transportation. By targeting these new markets, CorVel can diversify its revenue streams and reduce its reliance on existing clients. Timeline: Ongoing.
- Leveraging AI and Machine Learning: CorVel's investment in AI and machine learning provides a significant competitive advantage. The company can leverage these technologies to further automate its processes, improve the accuracy of its claims management, and enhance its ability to identify and mitigate risks. By continuing to innovate in this area, CorVel can maintain its leadership position in the risk management industry. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: CorVel can pursue strategic partnerships and acquisitions to expand its service offerings and market reach. By partnering with complementary businesses, CorVel can offer a more comprehensive suite of solutions to its clients. Acquisitions can provide access to new technologies, markets, and customer relationships, accelerating the company's growth. Timeline: Ongoing.
Opportunities
- Expansion into new geographic markets and industry segments.
- Growth in patient management services and value-based care models.
- Strategic partnerships and acquisitions to expand service offerings.
- Increased demand for technology-driven risk management solutions.
Threats
- Economic downturn impacting healthcare spending.
- Increased competition from existing and new players.
- Cybersecurity risks and data breaches.
- Changes in healthcare regulations and reimbursement models.
Competitive Advantages
- Proprietary technology platform leveraging AI and machine learning.
- Extensive network of healthcare providers and partners.
- Established relationships with a diverse customer base.
- Deep industry expertise in risk management and healthcare cost containment.
About
CorVel Corporation, founded in 1987 and headquartered in Fort Worth, Texas, has evolved into a leading provider of risk management solutions, primarily focused on workers' compensation, auto, liability, and health. The company's core business revolves around assisting employers, third-party administrators, insurance companies, and government agencies in effectively managing medical costs and ensuring quality care for healthcare claims. CorVel distinguishes itself through the application of advanced technology, including artificial intelligence, machine learning, and natural language processing, to enhance the management of care episodes and associated healthcare costs. Its comprehensive suite of services includes network solutions such as automated medical fee auditing, preferred provider management, retrospective utilization review, and pharmacy services. Additionally, CorVel offers patient management services, encompassing claims management, case management, 24/7 nurse triage, utilization management, and vocational rehabilitation. This holistic approach positions CorVel as a key partner for organizations seeking to optimize healthcare outcomes and control costs within the complex landscape of risk management.
What They Do
- Provides workers' compensation solutions to employers.
- Offers auto and liability claims management services.
- Delivers health solutions for managing medical costs.
- Applies AI and machine learning to enhance healthcare claims management.
- Offers automated medical fee auditing services.
- Provides preferred provider management and reimbursement services.
- Offers 24/7 nurse triage and utilization management.
- Processes claims for self-insured payors.
Business Model
- Generates revenue through fees for network solutions services.
- Earns revenue from patient management services.
- Contracts with employers, third-party administrators, and insurance companies.
- Utilizes technology to streamline processes and reduce costs.
Industry Context
CorVel operates within the insurance brokerage industry, which is experiencing increasing demand for technology-driven solutions to manage healthcare costs and improve outcomes. The market is characterized by a competitive landscape, with companies like CorVel, AGO, ATH, CNO, FG, and FHI vying for market share. The industry is driven by factors such as rising healthcare costs, increasing regulatory scrutiny, and the need for efficient claims management. CorVel's focus on AI and data analytics positions it favorably within this evolving landscape, allowing it to capitalize on the growing demand for innovative risk management solutions.
Key Customers
- Employers seeking to manage workers' compensation costs.
- Third-party administrators processing healthcare claims.
- Insurance companies managing auto and liability claims.
- Government agencies requiring risk management solutions.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $236M | $24M | $0.47 |
| Q3 2025 | $240M | $28M | $0.54 |
| Q2 2025 | $235M | $27M | $0.52 |
| Q1 2025 | $232M | $26M | $0.51 |
Source: Company filings
Chart & Info
Price Chart
CorVel Corporation (CRVL) stock price: $50.57 (+0.00, +0.00%)
Why Bull
- •Recent insider buying has signaled confidence in CorVel's future growth, indicating that management believes in the company's trajectory.
- •Community sentiment has turned positive, with discussions highlighting the company's strong service offerings and potential market expansion.
- •Analysts have noted CorVel's resilience in navigating regulatory changes, which could position the company favorably in the evolving healthcare landscape.
- •The company's recent partnerships in the workers' compensation sector have generated buzz, suggesting increased revenue opportunities ahead.
Why Bear
- •Some investors are concerned about the competitive pressures in the healthcare management space, which could impact CorVel's market share.
- •Recent discussions have highlighted challenges in scaling operations efficiently, raising doubts about long-term profitability.
- •There are worries about potential regulatory hurdles that could affect operational flexibility and profit margins.
- •Market sentiment has shown skepticism regarding the sustainability of recent growth trends, with some community members calling for caution.
Latest News
-
Earnings Scheduled For February 3, 2026
benzinga · Feb 3, 2026
-
Earnings Scheduled For February 3, 2026
Benzinga · Feb 3, 2026
Technical Analysis
Rationale
AI-generated technical analysis for CRVL including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss CorVel Corporation (CRVL) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for CRVL.
Make a Prediction
Set your price target for CorVel Corporation (CRVL), choose a timeframe, and track your prediction accuracy.
Current price: $50.57
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRVL.
Price Targets
Wall Street price target analysis for CRVL.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 4/100
Revenue grew only 12.6% YoY, suggesting the company is in a slower growth phase.
-
Gross Margin 6/100
Gross margin of 24.2% is acceptable but leaves limited room for R&D and marketing investment.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 8/100
Strong cash reserves of $171M provide a solid financial cushion for growth investments and market downturns.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 3/100
Net insider selling of -$0.96M may indicate reduced confidence or routine diversification by executives.
-
Short Interest 10/100
Daily turnover of 1.12% indicates healthy liquidity with smooth entry/exit for investors.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
News sentiment is mixed, with a balance of positive and negative coverage in recent days.
What does this score mean?
The MoonshotScore rates CRVL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Frequently Asked Questions
What does CorVel Corporation do?
CorVel Corporation specializes in providing technology-driven risk management solutions primarily focused on workers' compensation, auto, liability, and health. The company's core business revolves around assisting employers, third-party administrators, insurance companies, and government agencies in effectively managing medical costs and ensuring quality care for healthcare claims. CorVel distinguishes itself through the application of advanced technology, including artificial intelligence, machine learning, and natural language processing, to enhance the management of care episodes and associated healthcare costs.
Is CRVL stock a good buy?
CRVL stock may be a good buy for investors seeking exposure to the growing risk management sector. With a P/E ratio of 23.68 and a profit margin of 11.2%, CorVel demonstrates financial stability. The company's focus on technology-driven solutions and expansion into new markets presents significant growth potential. However, investors should also consider the potential risks, such as economic downturns and increased competition, before making an investment decision.
What are the main risks for CRVL?
The main risks for CRVL include economic downturns impacting healthcare spending, increased competition from larger companies, cybersecurity risks, and changes in healthcare regulations. An economic downturn could lead to reduced client budgets and decreased demand for CorVel's services. Increased competition could erode market share and pressure pricing. Cybersecurity risks could result in data breaches and reputational damage. Changes in healthcare regulations could impact the company's business model and profitability.
Is CRVL a good stock to buy?
Whether CRVL is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate CorVel Corporation's revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.
What is the CRVL MoonshotScore?
The MoonshotScore rates CRVL from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.
How often is CRVL data updated?
CRVL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What do analysts say about CRVL?
Analyst coverage for CRVL includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.
What are the risks of investing in CRVL?
Risk categories for CRVL include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is based on the most recent available information. Future performance is subject to market conditions and company-specific factors.